Dysregulation of ABPs is implicated in various diseases, including cancer, neurodegenerative diseases, and cardiovascular disorders. For instance, aberrant activity of cofilin has been associated with metastatic cancer cells, which exhibit increased motility and invasion. Moreover, mutations in ABPs like dystrophin are linked to muscular dystrophies, highlighting the critical role of these proteins in maintaining cellular integrity and function.
